FridayApr 09, 2021 2:39 pm

Research Discovers Vaccinating Women Against COVID-19 Passes Antibodies to Unborn Babies

Researchers from Harvard, MIT, the Ragon Institute of MGH, Brigham and Women’s Hospital and Massachusetts General Hospital recently conducted a study that discovered that the new mRNA coronavirus vaccines were highly efficacious in producing antibodies against the SARS-CoV-2 virus in lactating and pregnant women. The researchers also showed that the vaccines offered protective immunity to newborns through the placenta and breast milk. Their findings were reported in the “American Journal of Obstetrics and Gynecology” and observed 131 women, 16 of whom weren’t pregnant, 31 who were lactating and 84 who were pregnant, all of reproductive age. All the study participants…

Continue Reading

FridayApr 09, 2021 2:26 pm

RYAH Group Inc. Offers IoT Suite of Products Disrupting Future of Medicine

Every product features three parts: dosing device, formulation accessory and mobile app HIPPA-compliant cloud collects data along each step that is essential in tailoring personalized treatment plan RYAH offers multi-product ecosystem that provides remote-health solutions in patient treatment RYAH Group a digital health-care analytics and technology company, has developed an ecosystem of IoT products in its mission to advance the world's transition to remote-health solutions and data analytics in patient treatments (https://ibn.fm/1wvz4). Every product features three parts: the device, the formulation accessory (QR labeled product) and the mobile application. These parts work together to control the dosing while also capturing important…

Continue Reading

ThursdayApr 08, 2021 2:30 pm

Researchers Find That Dining Out Frequently Increases Risk of Mortality

Researchers from the University of Iowa recently examined the link between the risk of death and dining out and came to the conclusion that eating out too often was linked to an increased risk of all-cause death. The findings were reported in the “Journal of the Academy of Nutrition and Dietetics.” Eating out is a popular activity globally, and while not much research has been done into its link with health outcomes, the conclusion warrants further study on the matter. The U.S. Department of Agriculture estimates that the daily energy intake from food away from home for Americans had increased…

Continue Reading

ThursdayApr 08, 2021 2:24 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commercialization Team Set to Launch Rapid POC COVID Test Solution

Bioscience technology accelerator XPhyto Therapeutics Corp. is working with development partner 3a-diagnostics GmbH to roll out its pandemic-related virus diagnostic tool for the European market planned in April The test solution, dubbed “Covid-ID Lab,” received European regulatory approval last month XPhyto’s product is designed to be portable and rapid in its response time to help decrease testing operation costs and increase convenience of use News reports about the COVID-19 pandemic reflect a growing optimism that vaccine, mask and distancing protocols may be helping to drive down infection rates, although the reports note the virus continues to have a deadly effect…

Continue Reading

ThursdayApr 08, 2021 1:08 pm

Brain Scientific Inc. (BRSF) Meeting the Needs of Neuro Research

BRSF is creating mobile, easy-to-use electroencephalogram (“EEG”) devices that enhance research integrity There is an increasing desire to understand the brain’s capabilities and harness them for healing Brain Scientific provides a cost-efficient, pre-gelled, disposable and wireless solution that provides the same signal quality as the traditional wired EEG A growing consumer market for brain-computer interface (“BCI”) technology has some researchers worried about the quality of the data being collected. Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has developed wireless, portable, easy-to-use electroencephalogram (“EEG”) devices that do not compromise research integrity. Data collected from consumer-centric, low-cost BCIs…

Continue Reading

WednesdayApr 07, 2021 2:43 pm

Patients with Incurable Brain Cancers Find New Hope in University Study, Upcoming CNS Pharmaceuticals (NASDAQ: CNSP) Clinical Trial

Glioblastoma Multiforme (often known simply as GBM) is a fatal, incurable class of brain cancers that usually leaves patients only about 15 months to live once they are diagnosed A recent study by the Washington University School of Medicine found that the length of survivability appeared to improve when the standard chemotherapy regimen was given in the morning instead of the evening Brain cancer drug developer CNS Pharmaceuticals is also working on a solution to improve the quality of GBM care, seeing hope in its lead drug candidate, Berubicin, which showed promise in a small Phase 1 trial nearly 15…

Continue Reading

WednesdayApr 07, 2021 12:00 pm

Researchers Find Evidence Suggesting That Coronavirus Can Cause Type 2 Diabetes

A group of scientists from Monash University and King’s College London has developed a database of information that may help researchers find the link between type 2 diabetes and the coronavirus. The group designed the database for the following reasons: first, the increasing evidence that suggests that the coronavirus can actually cause individuals to become diabetic, and second, when compared to the general population, individuals who have type 2 diabetes are more likely to experience serious coronavirus symptoms and to die from the disease. Type 2 diabetes is a chronic condition that impacts the way the body processes blood sugar.…

Continue Reading

WednesdayApr 07, 2021 11:55 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Imaging Technology Overcoming Challenges Involving Bladder Cancer Visualization

90% of the cystoscopies performed on bladder cancer patients use white light, which cannot always detect cancer margins or tumors that lie flat against the bladder wall. The American Urology Association recommends blue light for cystoscopic procedures involving bladder cancer. Imagin Medical’s i/Blue Imaging System(TM) provides the simultaneous, side-by-side display of white light and blue light images, making it easier to visualize cancer margins and flat tumors, potentially resulting in lower recurrence rates The company is has transitioned to the manufacturing stage of the i/Blue System with their contract manufacturer, Lighthouse Imaging Bladder cancer is the sixth most prevalent cancer…

Continue Reading

TuesdayApr 06, 2021 1:01 pm

Healthy Extracts Inc.’s (HYEX) “Live Life Young Again” Strategy Reflects The Company’s Continued Optimism For 2021

Healthy Extracts Inc. recently declared its 2020 Q4 results, with revenue growth at 71% over the previous year The company’s 2021 strategy “Live Life Young Again” aligns with its plant-based product range and its overall confidence for 2021 Results of the clinical studies of the Fuel4Thought Brain Booster product were published in the renowned World Journal of Advanced Research and Reviews Healthy Extracts (OTCQB: HYEX), is engaged in the research, development, and sale of natural plant-based products that concentrate on nerve and heart health. The company’s growth and expansion are evident in the company’s robust 2020 Q4 results. Their latest financial…

Continue Reading

TuesdayApr 06, 2021 12:30 pm

Researchers Create Lab-Made Heart Valves That Grow with Patient

A recent study led by researchers from the University of Minnesota, both from the College of Science and Engineering and the Medical School, demonstrated how heart valves that were developed in the lab and infixed in young lambs for a year could grow in the recipient. When tested in the same lamb model, the researchers found that the valves demonstrated decreased calcification and better flow of blood function in comparison with valves derived from animals. If those results are confirmed in humans, these heart valves may help prevent multiple valve replacement surgeries for children born annually with heart defects. Additionally,…

Continue Reading

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050